Skip to main content
. Author manuscript; available in PMC: 2014 Jul 10.
Published in final edited form as: Cancer Lett. 2013 Feb 10;335(1):41–51. doi: 10.1016/j.canlet.2013.01.054

Figure 7.

Figure 7

Representative photo micrograph of CD31 immunostaining (20x) in Panc215 and Panc354. In Panc215, treatment with PF-03084014 or combination of GEM plus PF-03084014 leads to a significant reduction in endothelial-specific antigen CD-31, when compared to vehicle-treated tumors. Arrowheads point towards CD31 stained endothelial cells. *p<05, ***p<0.0001 vs. control; ##p<0.001 vs. GEM.